Watch BFNH. Know when insiders buy.
One email the day a filing lands. Free.
BFNH
BIOFORCE NANOSCIENCES HOLDINGS, INC.
6.82
+0.12 +1.79%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $228.8MP/E 682.0DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$98KNET CASH —52W 0.18 – 10.01SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | — | $239K | — | 0.01 | −$27K | — | — | Aug 10 |
| Q1 2026 · Mar 31 | — | — | — | — | −$102K | — | 0.00 | $7K | — | — | May 19 |
| Q4 2025 · Dec 31derived | — | — | — | — | −$119K | — | 0.00 | −$11K | — | — | Apr 15 |
| Q3 2025 · Sep 30 | — | — | — | −$116K | −$116K | — | 0.00 | −$11K | — | — | Nov 19 |
| Q2 2025 · Jun 30 | — | — | — | −$123K | −$123K | — | 0.00 | −$28K | — | — | Aug 10 |
| Q1 2025 · Mar 31 | — | — | — | −$133K | −$935K | — | -0.03 | −$15K | — | — | May 19 |
| Q4 2024 · Dec 31derived | — | — | — | — | −$123K | — | -0.01 | −$15K | — | — | Apr 15 |
| Q3 2024 · Sep 30 | — | — | — | −$122K | −$122K | — | 0.00 | −$15K | — | — | Nov 19 |
| Q2 2024 · Jun 30 | — | — | — | −$114K | −$114K | — | 0.00 | −$13K | — | — | Aug 11 |
| Q1 2024 · Mar 31 | — | — | — | — | −$131K | — | 0.00 | −$18K | — | — | May 13 |
| Q4 2023 · Dec 31derived | — | — | — | — | −$114K | — | -0.01 | −$7K | — | — | Apr 8 |
| Q3 2023 · Sep 30 | — | — | — | — | −$114K | — | 0.00 | −$8K | — | — | Nov 8 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | — | −$1.3M | — | -0.04 | −$65K | — | — | — | — |
| FY2024 · to Dec 31 | — | — | — | −$490K | — | -0.02 | −$61K | — | — | — | — |
| FY2023 · to Dec 31 | — | — | — | −$472K | — | -0.02 | −$47K | — | — | — | — |
| FY2022 · to Dec 31 | — | — | — | −$486K | — | -0.02 | −$68K | — | — | — | — |
| FY2021 · to Dec 31 | — | — | — | −$502K | — | -0.02 | −$78K | — | — | — | — |
| FY2020 · to Dec 31 | — | — | — | −$158.4M | — | -9.72 | −$80K | — | — | — | — |
Every number comes from BIOFORCE NANOSCIENCES HOLDINGS, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.